JP Stock MarketDetailed Quotes

4536 Santen Pharmaceutical

Watchlist
  • 1770.0
  • -9.0-0.51%
20min DelayMarket Closed Jul 26 15:00 JST
644.27BMarket Cap24.46P/E (Static)

Santen Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Santen Pharmaceutical Earnings Date

Currency: JPY

Period

Q1 FY2025 Estimates

Aug 6, 2024

Revenue(YoY)

73.94B

+2.14%
EPS(YoY)

22.64

-18.94%
Analyst Rating

Buy

Jul 26, 2024

Santen Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 3 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 73.938B--
Aug 6, 20242025/Q1-- / 73.939B--
May 9, 20242024/Q479.132B / 78.097B--
Feb 8, 20242024/Q377.027B / 73.700B--
Nov 7, 20232024/Q273.417B / 66.056B--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q2-- / 73.938B--
Aug 6, 20242025/Q1-- / 73.939B--
May 9, 20242024/Q479.132B / 78.097B--
Feb 8, 20242024/Q377.027B / 73.700B--
Nov 7, 20232024/Q273.417B / 66.056B--

Unlock Free Earnings Estimates

Santen Pharmaceutical Earnings Reports

  • Santen Pharmaceutical: Interim report

    Jun 25 20:45 ET

  • Santen Pharmaceutical: Extraordinary Report

    Jun 25 02:57 ET

  • Santen Pharmaceutical: Confirmation letter

    Jun 25 02:46 ET

  • Santen Pharmaceutical: Securities Report - 112th Period (April 1, 2023 to March 31, 2024)

    Jun 25 02:45 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Jul 26, 2024

    Buy

    • Strong Buy

      40.00%

    • Buy

      20.00%

    • Hold

      30.00%

    • Underperform

      10.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg